Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association

M. J Pekka Raatikainen, David O. Arnar, B. Merkely, A. John Camm, Gerhardt Hindricks

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Aims The aim of this analysis was to provide comprehensive information on the access to and use of cardiac implantable electronic device (CIED) and catheter ablation therapy in the European Society of Cardiology (ESC) area. Methods and results The European Heart Rhythm Association (EHRA) has been collecting descriptive and quantitative data on invasive arrhythmia therapies since 2008. This year 50 of the 56 ESC member countries provided data for the EHRA White Book. Up-to-date information on procedure rates for the last 5 years together with information on demographics, economy, vital statistics, local healthcare systems, and training activities is presented for each country and the 5 geographical ESC regions. Our analysis indicated that considerable heterogeneity in the access to arrhythmia therapies still exists across the ESC area. In 2015, the CIED implantation rates per million population were highest in the Western followed by the Southern and Northern European countries. The catheter ablation activity was largest in the Western followed by the Northern and Southern areas. Overall, the procedure rates were 3-10 times higher in the European than in the non-European ESC countries. Economic resources were not the only driver for utilization of arrhythmia therapies as in some Eastern European countries with relative low gross domestic product the procedure rates exceeded the average values. Conclusion These data will help the healthcare professionals and stakeholders to identify and to understand in more depth the trends, disparities, and gaps in cardiac arrhythmia care and thereby promote harmonization of cardiac arrhythmias therapies in the ESC area.

Original languageEnglish
Pages (from-to)iii1-iii79
JournalEuropace
Volume18
DOIs
Publication statusPublished - Aug 1 2016

Fingerprint

Cardiology
Cardiac Arrhythmias
Equipment and Supplies
Catheter Ablation
Gross Domestic Product
Delivery of Health Care
Therapeutics
Vital Statistics
Access to Information
Teaching
Economics
Demography
Population

Keywords

  • Atrial fibrillation ablation
  • Cardiac resynchronization defibrillator (CRT-D)
  • Cardiac resynchronization pacemaker (CRT-P)
  • Catheter ablation
  • Implantable cardioverter-defibrillator (ICD)
  • Pacemaker

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries : 2016 Report from the European Heart Rhythm Association. / Raatikainen, M. J Pekka; Arnar, David O.; Merkely, B.; Camm, A. John; Hindricks, Gerhardt.

In: Europace, Vol. 18, 01.08.2016, p. iii1-iii79.

Research output: Contribution to journalArticle

@article{7eea1abe172846ffba407987f032d7c4,
title = "Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association",
abstract = "Aims The aim of this analysis was to provide comprehensive information on the access to and use of cardiac implantable electronic device (CIED) and catheter ablation therapy in the European Society of Cardiology (ESC) area. Methods and results The European Heart Rhythm Association (EHRA) has been collecting descriptive and quantitative data on invasive arrhythmia therapies since 2008. This year 50 of the 56 ESC member countries provided data for the EHRA White Book. Up-to-date information on procedure rates for the last 5 years together with information on demographics, economy, vital statistics, local healthcare systems, and training activities is presented for each country and the 5 geographical ESC regions. Our analysis indicated that considerable heterogeneity in the access to arrhythmia therapies still exists across the ESC area. In 2015, the CIED implantation rates per million population were highest in the Western followed by the Southern and Northern European countries. The catheter ablation activity was largest in the Western followed by the Northern and Southern areas. Overall, the procedure rates were 3-10 times higher in the European than in the non-European ESC countries. Economic resources were not the only driver for utilization of arrhythmia therapies as in some Eastern European countries with relative low gross domestic product the procedure rates exceeded the average values. Conclusion These data will help the healthcare professionals and stakeholders to identify and to understand in more depth the trends, disparities, and gaps in cardiac arrhythmia care and thereby promote harmonization of cardiac arrhythmias therapies in the ESC area.",
keywords = "Atrial fibrillation ablation, Cardiac resynchronization defibrillator (CRT-D), Cardiac resynchronization pacemaker (CRT-P), Catheter ablation, Implantable cardioverter-defibrillator (ICD), Pacemaker",
author = "Raatikainen, {M. J Pekka} and Arnar, {David O.} and B. Merkely and Camm, {A. John} and Gerhardt Hindricks",
year = "2016",
month = "8",
day = "1",
doi = "10.1093/europace/euw244",
language = "English",
volume = "18",
pages = "iii1--iii79",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries

T2 - 2016 Report from the European Heart Rhythm Association

AU - Raatikainen, M. J Pekka

AU - Arnar, David O.

AU - Merkely, B.

AU - Camm, A. John

AU - Hindricks, Gerhardt

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Aims The aim of this analysis was to provide comprehensive information on the access to and use of cardiac implantable electronic device (CIED) and catheter ablation therapy in the European Society of Cardiology (ESC) area. Methods and results The European Heart Rhythm Association (EHRA) has been collecting descriptive and quantitative data on invasive arrhythmia therapies since 2008. This year 50 of the 56 ESC member countries provided data for the EHRA White Book. Up-to-date information on procedure rates for the last 5 years together with information on demographics, economy, vital statistics, local healthcare systems, and training activities is presented for each country and the 5 geographical ESC regions. Our analysis indicated that considerable heterogeneity in the access to arrhythmia therapies still exists across the ESC area. In 2015, the CIED implantation rates per million population were highest in the Western followed by the Southern and Northern European countries. The catheter ablation activity was largest in the Western followed by the Northern and Southern areas. Overall, the procedure rates were 3-10 times higher in the European than in the non-European ESC countries. Economic resources were not the only driver for utilization of arrhythmia therapies as in some Eastern European countries with relative low gross domestic product the procedure rates exceeded the average values. Conclusion These data will help the healthcare professionals and stakeholders to identify and to understand in more depth the trends, disparities, and gaps in cardiac arrhythmia care and thereby promote harmonization of cardiac arrhythmias therapies in the ESC area.

AB - Aims The aim of this analysis was to provide comprehensive information on the access to and use of cardiac implantable electronic device (CIED) and catheter ablation therapy in the European Society of Cardiology (ESC) area. Methods and results The European Heart Rhythm Association (EHRA) has been collecting descriptive and quantitative data on invasive arrhythmia therapies since 2008. This year 50 of the 56 ESC member countries provided data for the EHRA White Book. Up-to-date information on procedure rates for the last 5 years together with information on demographics, economy, vital statistics, local healthcare systems, and training activities is presented for each country and the 5 geographical ESC regions. Our analysis indicated that considerable heterogeneity in the access to arrhythmia therapies still exists across the ESC area. In 2015, the CIED implantation rates per million population were highest in the Western followed by the Southern and Northern European countries. The catheter ablation activity was largest in the Western followed by the Northern and Southern areas. Overall, the procedure rates were 3-10 times higher in the European than in the non-European ESC countries. Economic resources were not the only driver for utilization of arrhythmia therapies as in some Eastern European countries with relative low gross domestic product the procedure rates exceeded the average values. Conclusion These data will help the healthcare professionals and stakeholders to identify and to understand in more depth the trends, disparities, and gaps in cardiac arrhythmia care and thereby promote harmonization of cardiac arrhythmias therapies in the ESC area.

KW - Atrial fibrillation ablation

KW - Cardiac resynchronization defibrillator (CRT-D)

KW - Cardiac resynchronization pacemaker (CRT-P)

KW - Catheter ablation

KW - Implantable cardioverter-defibrillator (ICD)

KW - Pacemaker

UR - http://www.scopus.com/inward/record.url?scp=85010764993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010764993&partnerID=8YFLogxK

U2 - 10.1093/europace/euw244

DO - 10.1093/europace/euw244

M3 - Article

C2 - 27496955

AN - SCOPUS:85010764993

VL - 18

SP - iii1-iii79

JO - Europace

JF - Europace

SN - 1099-5129

ER -